A Preliminary Study to Evaluate the Effects of Palifermin in Patients at Risk of Chronic Graft-versus-host Disease.
Phase of Trial: Phase I
Latest Information Update: 06 Dec 2012
At a glance
- Drugs Palifermin (Primary)
- Indications Graft-versus-host disease
- Focus Biomarker; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 06 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.